These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. A Nine-Year Follow-Up of Macular Complications in Retinitis Pigmentosa and Diabetes Mellitus. Mucciolo DP; Sodi A; Murro V; Virgili G; Rizzo S Ophthalmic Surg Lasers Imaging Retina; 2017 Apr; 48(4):340-344. PubMed ID: 28419400 [TBL] [Abstract][Full Text] [Related]
23. Optical Coherence Tomography Features in Diabetic Macular Edema and the Impact on Anti-VEGF Response. Itoh Y; Petkovsek D; Kaiser PK; Singh RP; Ehlers JP Ophthalmic Surg Lasers Imaging Retina; 2016 Oct; 47(10):908-913. PubMed ID: 27759856 [TBL] [Abstract][Full Text] [Related]
24. CCNET: Cross Coordinate Network for Joint Diabetic Retinopathy and Diabetic Macular Edema Grading. Yue T; Yang W; Liao Q Annu Int Conf IEEE Eng Med Biol Soc; 2022 Jul; 2022():2062-2065. PubMed ID: 36085646 [TBL] [Abstract][Full Text] [Related]
25. Comments on: Long-term results of a single injection of intravitreal dexamethasone as initial therapy in diabetic macular edema. Sahu V; Misra S Indian J Ophthalmol; 2021 Jan; 69(1):188-189. PubMed ID: 33323636 [No Abstract] [Full Text] [Related]
26. Comments on: Long-term results of a single injection of intravitreal dexamethasone as initial therapy in diabetic macular edema. Verghese S; Ranjan R; Manayath GJ Indian J Ophthalmol; 2021 Jan; 69(1):186-187. PubMed ID: 33323634 [No Abstract] [Full Text] [Related]
27. Response to comments on: Long-term results of a single injection of intravitreal dexamethasone as initial therapy in diabetic macular edema. Mahapatra SK; Kumari S Indian J Ophthalmol; 2021 Jan; 69(1):189-190. PubMed ID: 33323637 [No Abstract] [Full Text] [Related]
28. Response to comments on: Long-term results of a single injection of intravitreal dexamethasone as initial therapy in diabetic macular edema. Mahapatra SK; Kumari S Indian J Ophthalmol; 2021 Jan; 69(1):187-188. PubMed ID: 33323635 [No Abstract] [Full Text] [Related]
29. Repeated Dexamethasone Intravitreal Implant for the Treatment of Diabetic Macular Oedema Unresponsive to Anti-VEGF Therapy: Outcome and Predictive SD-OCT Features. Hatz K; Ebneter A; Tuerksever C; Pruente C; Zinkernagel M Ophthalmologica; 2018; 239(4):205-214. PubMed ID: 29402873 [TBL] [Abstract][Full Text] [Related]
30. Detailed analysis of retinal morphology in patients with diabetic macular edema (DME) randomized to ranibizumab or triamcinolone treatment. Karst SG; Lammer J; Mitsch C; Schober M; Mehta J; Scholda C; Kundi M; Kriechbaum K; Schmidt-Erfurth U Graefes Arch Clin Exp Ophthalmol; 2018 Jan; 256(1):49-58. PubMed ID: 29080915 [TBL] [Abstract][Full Text] [Related]
31. Immune thrombocytopenic purpura presenting in a patient after renal transplant for diabetic nephropathy. Rashid RM; Nabi Z; Ansari AZ; Qaiser QA BMC Nephrol; 2018 Mar; 19(1):69. PubMed ID: 29554892 [TBL] [Abstract][Full Text] [Related]
32. Current intravitreal pharmacologic therapies for diabetic macular edema. Colucciello M Postgrad Med; 2015 Aug; 127(6):640-53. PubMed ID: 26036708 [TBL] [Abstract][Full Text] [Related]
33. The effects of hyperbaric oxygen therapy on diabetic retinopathy: A preliminary study. Maalej A; Khallouli A; Choura R; Ben Sassi R; Rannen R; Gharsallah H J Fr Ophtalmol; 2020 Feb; 43(2):133-138. PubMed ID: 31831276 [TBL] [Abstract][Full Text] [Related]
34. Longitudinal Study of Sustained-Release Dexamethasone Intravitreal Implant in Patients with Diabetic Macular Edema. Aknin I; Melki L Ophthalmologica; 2016; 235(4):187-8. PubMed ID: 27169611 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of the New "SAVE" Protocol in Diabetic Macular Edema Over the Course of Anti-VEGF Treatment. Reznicek L; Bolz M; Garip A; Kampik A; Kernt M; Mayer WJ Curr Eye Res; 2016 Aug; 41(8):1082-1086. PubMed ID: 26580417 [TBL] [Abstract][Full Text] [Related]
36. Long-term results of a single injection of intravitreal dexamethasone as initial therapy in diabetic macular edema. Mahapatra SK; Kumari S Indian J Ophthalmol; 2020 Mar; 68(3):490-493. PubMed ID: 32057010 [TBL] [Abstract][Full Text] [Related]
37. Predicting outcomes to anti-vascular endothelial growth factor (VEGF) therapy in diabetic macular oedema: a review of the literature. Ashraf M; Souka A; Adelman R Br J Ophthalmol; 2016 Dec; 100(12):1596-1604. PubMed ID: 27231313 [TBL] [Abstract][Full Text] [Related]
38. Study of aqueous cytokines in patients with different patterns of diabetic macular edema based on optical coherence tomography. Bandyopadhyay S; Bandyopadhyay SK; Saha M; Sinha A Int Ophthalmol; 2018 Feb; 38(1):241-249. PubMed ID: 28160192 [TBL] [Abstract][Full Text] [Related]
39. Aqueous Humor Levels of Soluble Vascular Endothelial Growth Factor Receptor and Inflammatory Factors in Diabetic Macular Edema. Noma H; Mimura T; Yasuda K; Motohashi R; Kotake O; Shimura M Ophthalmologica; 2017; 238(1-2):81-88. PubMed ID: 28564655 [TBL] [Abstract][Full Text] [Related]
40. Comparison of two individualized treatment regimens with ranibizumab for diabetic macular edema. Ebneter A; Waldmeier D; Zysset-Burri DC; Wolf S; Zinkernagel MS Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):549-555. PubMed ID: 27714513 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]